UGT2A3
Basic information
Region (hg38): 4:68928463-68951804
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the UGT2A3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 39 | 41 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 39 | 2 | 0 |
Variants in UGT2A3
This is a list of pathogenic ClinVar variants found in the UGT2A3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-68929817-T-C | not specified | Uncertain significance (Jan 07, 2022) | ||
4-68929859-G-A | not specified | Uncertain significance (Jul 20, 2021) | ||
4-68929882-C-A | not specified | Uncertain significance (Jan 03, 2024) | ||
4-68929956-G-A | not specified | Uncertain significance (Sep 13, 2023) | ||
4-68929973-C-G | not specified | Uncertain significance (Feb 21, 2024) | ||
4-68929997-C-T | not specified | Uncertain significance (Jul 20, 2022) | ||
4-68929998-G-A | not specified | Uncertain significance (Dec 01, 2022) | ||
4-68930054-T-C | not specified | Uncertain significance (Feb 10, 2023) | ||
4-68930619-C-T | not specified | Uncertain significance (Sep 16, 2021) | ||
4-68930624-G-T | not specified | Uncertain significance (Jan 06, 2023) | ||
4-68930634-C-T | not specified | Uncertain significance (Sep 14, 2023) | ||
4-68930657-A-T | not specified | Uncertain significance (May 13, 2024) | ||
4-68930669-A-G | not specified | Uncertain significance (Nov 12, 2021) | ||
4-68931165-A-T | not specified | Uncertain significance (Feb 27, 2023) | ||
4-68931190-C-T | not specified | Likely benign (Oct 02, 2023) | ||
4-68931191-G-A | not specified | Uncertain significance (Jan 08, 2024) | ||
4-68931194-T-A | not specified | Uncertain significance (Mar 20, 2024) | ||
4-68932635-G-C | not specified | Uncertain significance (Nov 08, 2022) | ||
4-68932680-G-A | not specified | Uncertain significance (Dec 17, 2023) | ||
4-68932689-T-C | not specified | Uncertain significance (Aug 08, 2023) | ||
4-68932689-T-G | not specified | Uncertain significance (Dec 17, 2023) | ||
4-68932747-A-C | not specified | Uncertain significance (Apr 01, 2022) | ||
4-68945316-G-A | not specified | Uncertain significance (Mar 29, 2022) | ||
4-68945323-C-A | not specified | Uncertain significance (Jan 18, 2023) | ||
4-68945371-G-C | not specified | Uncertain significance (Mar 14, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
UGT2A3 | protein_coding | protein_coding | ENST00000251566 | 6 | 23329 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.26e-15 | 0.00601 | 125623 | 0 | 103 | 125726 | 0.000410 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.75 | 354 | 272 | 1.30 | 0.0000128 | 3448 |
Missense in Polyphen | 128 | 100.05 | 1.2793 | 1379 | ||
Synonymous | -2.80 | 131 | 96.1 | 1.36 | 0.00000459 | 992 |
Loss of Function | -0.307 | 22 | 20.5 | 1.07 | 0.00000115 | 252 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00119 | 0.00118 |
Ashkenazi Jewish | 0.000200 | 0.000198 |
East Asian | 0.000388 | 0.000381 |
Finnish | 0.0000463 | 0.0000462 |
European (Non-Finnish) | 0.000443 | 0.000422 |
Middle Eastern | 0.000388 | 0.000381 |
South Asian | 0.000597 | 0.000588 |
Other | 0.000168 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: UDP-glucuronosyltransferases catalyze phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase water solubility and enhance excretion. They are of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds (By similarity). {ECO:0000250}.;
- Pathway
- Retinol metabolism - Homo sapiens (human);Steroid hormone biosynthesis - Homo sapiens (human);Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human);Drug metabolism - other enzymes - Homo sapiens (human);Drug metabolism - cytochrome P450 - Homo sapiens (human);Porphyrin and chlorophyll metabolism - Homo sapiens (human);Chemical carcinogenesis - Homo sapiens (human);Ascorbate and aldarate metabolism - Homo sapiens (human);Pentose and glucuronate interconversions - Homo sapiens (human);Glucuronidation;Metapathway biotransformation Phase I and II;Glucuronidation;Phase II - Conjugation of compounds;Biological oxidations;Metabolism
(Consensus)
Recessive Scores
- pRec
- 0.139
Intolerance Scores
- loftool
- 0.828
- rvis_EVS
- 0.38
- rvis_percentile_EVS
- 75.63
Haploinsufficiency Scores
- pHI
- 0.335
- hipred
- N
- hipred_score
- 0.112
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0437
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ugt2a3
- Phenotype
Gene ontology
- Biological process
- cellular glucuronidation
- Cellular component
- integral component of membrane;intracellular membrane-bounded organelle
- Molecular function
- UDP-glycosyltransferase activity;glucuronosyltransferase activity